BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: October 2025

64 posts

Biotech NewsX4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside

  • BioTech Health X
  • October 20, 2025
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a late-stage clinical biopharmaceutical company founded with a mission to develop innovative therapies…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTenax (TENX) Could Be the Best-Funded Microcap in Biotech

  • BioTech Health X
  • October 20, 2025
Tenax Therapeutics, Inc. (NASDAQ:TENX) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for life-threatening…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCapricor Therapeutics (CAPR) Near All-Time Lows

  • BioTech Health X
  • October 20, 2025
Capricor Therapeutics (NASDAQ:CAPR) is a biotechnology company founded with a mission to develop transformative cell and exosome-based therapies…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWindtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs

  • BioTech Health X
  • October 20, 2025
Windtree Therapeutics Inc. (NASDAQ:WINT) is a diversified life sciences and emerging environmental services company with a long-established foundation…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSight Sciences (SGHT) Surges 37% in One Month

  • BioTech Health X
  • October 19, 2025
Sight Sciences Inc. (NASDAQ:SGHT) is a medical technology company dedicated to transforming the treatment of eye diseases through…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSELLAS (SLS) Surged 40% After Hours on New AML Data

  • BioTech Health X
  • October 19, 2025
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies designed…
0 Shares
0
0
0
0
0
0
0

Biotech NewsArtiva Biotherapeutics (ARTV) Rockets 116% in One Day

  • BioTech Health X
  • October 19, 2025
Artiva Biotherapeutics Inc. (NASDAQ:ARTV) is a clinical-stage biotechnology company pioneering the development of off-the-shelf, allogeneic natural killer (NK)…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAddex Therapeutics (ADXN) Targets $330 Million Milestone Payouts

  • BioTech Health X
  • October 19, 2025
Addex Therapeutics Ltd (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, focused on discovering and developing innovative…
0 Shares
0
0
0
0
0
0
0

Biotech NewsArcadia Biosciences (RKDA) Surges 53%, But EBITDA Is Still -$5.9 Million

  • BioTech Health X
  • October 19, 2025
Arcadia Biosciences Inc. (NASDAQ:RKDA) is an agricultural biotechnology company founded in 2002 with the mission of developing innovative,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBright Minds Biosciences (DRUG) Surges 158.8% in 12 Weeks

  • BioTech Health X
  • October 19, 2025
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a biotechnology company focused on developing next-generation therapeutics for neurological and psychiatric disorders…
0 Shares
0
0
0
0
0
0
0

Biotech NewsVanda Pharmaceuticals (VNDA) Targets 300% Upside with Breakthrough FDA Framework Deal

  • BioTech Health X
  • October 19, 2025
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is a biopharmaceutical company focused on the development and commercialization of innovative therapies that…
0 Shares
0
0
0
0
0
0
0

Biotech NewsDelcath (DCTH) Revenue Surges with 87% Gross Margin and Zero Debt Balance Sheet

  • BioTech Health X
  • October 19, 2025
Delcath Systems Inc. (NASDAQ:DCTH) is a specialty pharmaceutical and medical device company focused on developing and commercializing innovative therapies…
0 Shares
0
0
0
0
0
0
0

Biotech NewsResMed (RMD) Dominates $39.7 Billion Sleep Health Market

  • BioTech Health X
  • October 19, 2025
ResMed Inc. (NYSE:RMD) is a global leader in digital health and cloud-connected medical devices, specializing in innovative solutions…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBioMarin (BMRN)’s Rare Disease Portfolio Generates Over $2.4 Billion in Annual Revenue

  • BioTech Health X
  • October 19, 2025
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a pioneering biotechnology company specializing in the development and commercialization of therapies for…
0 Shares
0
0
0
0
0
0
0

Biotech NewsEdwards Lifesciences (EW) Set to Report $1.50B in Q3 Sales

  • BioTech Health X
  • October 19, 2025
Edwards Lifesciences Corporation (NYSE:EW) is a global medical technology leader dedicated to the advancement of patient-focused innovations in structural…
0 Shares
0
0
0
0
0
0
0

Biotech NewsNewAmsterdam Pharma (NAMS) Soars 93.9% in 12 Months

  • BioTech Health X
  • October 15, 2025
NewAmsterdam Pharma Co. N.V. (NASDAQ:NAMS) is a late-stage biopharmaceutical company dedicated to transforming the treatment of cardiovascular and…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTeva Pharma (TEVA) Wins FDA Approval for UZEDY’s Bipolar I Expansion

  • BioTech Health X
  • October 15, 2025
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the world’s largest and most established pharmaceutical companies, headquartered in…
0 Shares
0
0
0
0
0
0
0

Biotech NewsRadiopharm Theranostics (RADX) Halts Trading Ahead of Major Capital Raise

  • BioTech Health X
  • October 15, 2025
Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australian-based clinical-stage biotechnology company pioneering advancements in radiopharmaceuticals for both diagnostic imaging…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
  • Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
  • Capricor Therapeutics (CAPR) Near All-Time Lows
  • Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
  • Sight Sciences (SGHT) Surges 37% in One Month
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 20, 2025
    X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
    • October 20, 2025
    Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
    • October 20, 2025
    Capricor Therapeutics (CAPR) Near All-Time Lows
    • October 20, 2025
    Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
    • October 19, 2025
    Sight Sciences (SGHT) Surges 37% in One Month
Recent Posts
  • Candel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch
    • October 15, 2025
  • Teladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo
    • October 15, 2025
  • Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
    • October 14, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (491)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top